These findings have been validated and expanded by a recent study reporting that loss of KDM6A in bladder cancer cells results in dowregulation of polycomb repressive complex 2 (PRC2) target genes, in line with an antagonizing function between KDM6A and PRC2 (Figure 5) [27,144]. Here, KDM6A is linked to urinary bladder carcinoma.